|
|
|
|
LEADER |
02227 am a22002293u 4500 |
001 |
117733 |
042 |
|
|
|a dc
|
100 |
1 |
0 |
|a Fotoran, Wesley L.
|e author
|
100 |
1 |
0 |
|a Massachusetts Institute of Technology. Department of Biological Engineering
|e contributor
|
100 |
1 |
0 |
|a Massachusetts Institute of Technology. Department of Materials Science and Engineering
|e contributor
|
100 |
1 |
0 |
|a Koch Institute for Integrative Cancer Research at MIT
|e contributor
|
100 |
1 |
0 |
|a Irvine, Darrell J
|e contributor
|
700 |
1 |
0 |
|a Santangelo, Rachele
|e author
|
700 |
1 |
0 |
|a de Miranda, Beatriz N.M.
|e author
|
700 |
1 |
0 |
|a Wunderlich, Gerhard
|e author
|
700 |
1 |
0 |
|a Irvine, Darrell J
|e author
|
245 |
0 |
0 |
|a DNA-Loaded Cationic Liposomes Efficiently Function as a Vaccine against Malarial Proteins
|
260 |
|
|
|b Elsevier BV,
|c 2018-09-12T20:46:33Z.
|
856 |
|
|
|z Get fulltext
|u http://hdl.handle.net/1721.1/117733
|
520 |
|
|
|a The delivery of antigens as DNA vaccines is an efficient alternative to induce immune responses against antigens, which are difficult to produce in recombinant form. However, the delivery of naked DNA is ineffective or relies on sophisticated ballistic devices. Here, we show a combination of liposome application and naked DNA vaccine that successfully overcomes these problems. Upon entrapment of plasmids encoding different antigens in cationic particles, transfection efficiencies similar to commercial kits were achieved in in vitro cell cultures. The liposome-based approach provided strong humoral responses against three malarial antigens, namely the Circumsporozoite protein and the C terminus of merozoite surface protein 1 from Plasmodium vivax (titers 104or 103-104, respectively) and P. falciparum Rhoptry antigen 5 from Plasmodium falciparum (titers 103-104). When employed in P. falciparum growth-inhibition assays, antibodies demonstrated consistent reinvasion-blocking activities that were dose dependent. Liposome-formulated DNA vaccines may prove useful when targets cannot be produced as recombinant proteins and when conformation-dependent and highly specific antibodies are mandatory. Keywords: cationic liposomes; DNA vaccine; malaria
|
655 |
7 |
|
|a Article
|
773 |
|
|
|t Molecular Therapy - Methods & Clinical Development
|